Canaccord Genuity Maintains Hold on Staar Surgical, Lowers Price Target to $41
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Jon Young maintains a Hold rating on Staar Surgical (NASDAQ:STAA) but lowers the price target from $43 to $41.
August 08, 2024 | 12:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Canaccord Genuity analyst Jon Young maintains a Hold rating on Staar Surgical (NASDAQ:STAA) and lowers the price target from $43 to $41.
The lowered price target from $43 to $41 suggests a less optimistic outlook for Staar Surgical, which could negatively impact investor sentiment and short-term stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100